NEOLA Stock Overview
Develops medical equipment for continuous monitoring of the lungs of premature babies.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Neola Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr2.20 |
| 52 Week High | kr2.90 |
| 52 Week Low | kr1.16 |
| Beta | 0.87 |
| 1 Month Change | 7.84% |
| 3 Month Change | 37.50% |
| 1 Year Change | 29.41% |
| 3 Year Change | -44.44% |
| 5 Year Change | n/a |
| Change since IPO | -67.16% |
Recent News & Updates
Recent updates
Shareholder Returns
| NEOLA | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -14.7% | -1.9% | -1.5% |
| 1Y | 29.4% | -5.5% | 12.9% |
Return vs Industry: NEOLA exceeded the Swedish Medical Equipment industry which returned -5.5% over the past year.
Return vs Market: NEOLA exceeded the Swedish Market which returned 12.9% over the past year.
Price Volatility
| NEOLA volatility | |
|---|---|
| NEOLA Average Weekly Movement | 12.7% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.7% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: NEOLA's share price has been volatile over the past 3 months.
Volatility Over Time: NEOLA's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 7 | Hanna Sjostrom | www.neolamedical.se |
Neola Medical AB (publ) develops medical equipment for continuous monitoring of the lungs of premature babies. It offers neonatal intensive care with NEOLA, a medical device that offer continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. NEOLA provides intensive care and healthier lives for preterm born infants.
Neola Medical AB (publ) Fundamentals Summary
| NEOLA fundamental statistics | |
|---|---|
| Market cap | kr154.33m |
| Earnings (TTM) | -kr9.04m |
| Revenue (TTM) | kr10.93m |
14.1x
P/S Ratio-17.1x
P/E RatioIs NEOLA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEOLA income statement (TTM) | |
|---|---|
| Revenue | kr10.93m |
| Cost of Revenue | kr2.15m |
| Gross Profit | kr8.78m |
| Other Expenses | kr17.82m |
| Earnings | -kr9.04m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.13 |
| Gross Margin | 80.32% |
| Net Profit Margin | -82.70% |
| Debt/Equity Ratio | 0% |
How did NEOLA perform over the long term?
See historical performance and comparison